Locations:
SearchAdvertisement
Obstructing key protein allows for increased treatment uptake for taxane chemotherapy
Study demonstrates potential for improving access
Oral medication reduces epistaxis and improves quality of life for patients with rare vascular disorder
Findings could help with management of a common, dose-limiting side effect
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Enfortumab vedotin plus pembrolizumab benefited patients, regardless of biomarker expression
Treatment involved checkpoint inhibitor, surgery and intravesical therapy
Researchers Assess Real-Life Experiences of Patients Treated Outside of Clinical Trials
Multi-specialty coordination essential for improving quality of life
Seven-gene biosignature becomes first effective means to reduce over- and under-treatment with radiation therapy
Advertisement
Advertisement